Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Life Sciences
Data on life sciences published by researchers at University of Chicago, Brain Tumor Center
April 22nd, 2009
Data detailed in 'Targeted therapies for malignant glioma: progress and potential' have been presented. According to recent research published in the journal BioDrugs, "Malignant gliomas represent one of the most aggressive forms of brain cancer. Recent advances in the understanding of the deregulated molecular pathways of gliomas have brought about targeted therapies that have the ability to increase therapeutic efficacy in tumors while decreasing toxicity." "Multi-targeted kinase inhibitors, novel monoclonal antibodies, and new vaccines have been developed. Standard treatments and current development of new therapies for malignant gliomas are reviewed, focusing...
Source: Vaccine Weekly (2009-04-22)
|
